(Total Views: 292)
Posted On: 09/18/2017 5:11:12 PM
Post# of 346
NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Subsidiary Completes China FDA Filing; Moves toward Launch of Hemp-Infused Skin Care Line
Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX), through wholly-owned subsidiary CBD Biotechnology Co. Ltd., this morning announced that it has completed the record filing process with the China Food & Drug Administration (“CFDA”) for its first line of non-industrial hemp-infused skin care products. Following this milestone, the company expects to launch its ‘CBD Magic Hemp Series’ skin care line in the next couple of months, effectively positioning CBD Biotechnology as a leader in what the company has called “an untapped segment of China’s skin care industry.” “I am very pleased to announce the upcoming launch of CBD Biotechnology’s non-industrial hemp-infused skin care line, CBD Magic Hemp Series,” Summer Yun, CEO of CBD Biotechnology, stated in the news release. “We have not only completed the filing process with CFDA, but we have also contracted with a large processing factory in Shanghai, China, with over 14-years of experience in cosmetics production.” Upon launch, the initial CBD Magic Hemp Series product line is expected to include a brightening and refreshing moisturizer, a perfecting shield primer and a peptide collagen solution.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX), through wholly-owned subsidiary CBD Biotechnology Co. Ltd., this morning announced that it has completed the record filing process with the China Food & Drug Administration (“CFDA”) for its first line of non-industrial hemp-infused skin care products. Following this milestone, the company expects to launch its ‘CBD Magic Hemp Series’ skin care line in the next couple of months, effectively positioning CBD Biotechnology as a leader in what the company has called “an untapped segment of China’s skin care industry.” “I am very pleased to announce the upcoming launch of CBD Biotechnology’s non-industrial hemp-infused skin care line, CBD Magic Hemp Series,” Summer Yun, CEO of CBD Biotechnology, stated in the news release. “We have not only completed the filing process with CFDA, but we have also contracted with a large processing factory in Shanghai, China, with over 14-years of experience in cosmetics production.” Upon launch, the initial CBD Magic Hemp Series product line is expected to include a brightening and refreshing moisturizer, a perfecting shield primer and a peptide collagen solution.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
